ACTIVE

GILEAD SCIENCES BELGIUM

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

3,2 M €

-22.5% YoY

Revenue

118,4 M €

-16.2% YoY

Equity

35,7 M €

+9.8% YoY

Workforce

46,5 ETP

-7.4% YoY

What does GILEAD SCIENCES BELGIUM do?

GILEAD SCIENCES BELGIUM is a Private limited company incorporated in 2006. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 46,5 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0882.565.584

Incorporation

17/07/2006

Legal form

Private limited company

Registered office

Culliganlaan 2D
1831 Machelen (Brab.) · FlandreSee on map

Contributed capital

377 905,00 €

Latest accounts

31/12/2025

Average workforce

46,5 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	118,4 M €	-16.2%	141,3 M €	+26.0%	112,1 M €	+44.6%	77,5 M €	-1.8%	78,9 M €	-11.8%	89,5 M €	-11.1%	100,7 M €	+3.1%	97,7 M €	-19.6%	121,5 M €	+21.5%	100 M €	-9.8%	110,9 M €	+47.8%	75 M €	+25.6%	59,8 M €	+12.0%	53,3 M €	+9.6%	48,6 M €	+0.8%	48,2 M €	+68.2%	28,7 M €	+201%	9,5 M €		–		–
EBITDA	4,2 M €	-16.3%	5 M €	-24.1%	6,6 M €	+131%	2,9 M €	-2.1%	2,9 M €	-54.3%	6,4 M €	+109%	3,1 M €	-9.6%	3,4 M €	-31.4%	4,9 M €	+72.3%	2,9 M €	-14.4%	3,3 M €	+73.5%	1,9 M €	+13.7%	1,7 M €	+0.4%	1,7 M €	+25.6%	1,3 M €	+95.3%	687,1 k €	+22.5%	561,1 k €	+62.9%	344,5 k €	+2391%	-15 k €	+14.9%	-17,7 k €
Operating result	4,2 M €	-16.1%	5 M €	-24.3%	6,5 M €	+138%	2,8 M €	-1.9%	2,8 M €	-55.2%	6,3 M €	+114%	2,9 M €	-10.3%	3,3 M €	-28.7%	4,6 M €	+64.0%	2,8 M €	-13.6%	3,2 M €	+78.0%	1,8 M €	+13.6%	1,6 M €	-2.5%	1,6 M €	+26.9%	1,3 M €	+110%	613,9 k €	+23.9%	495,6 k €	+63.6%	302,8 k €	+2114%	-15 k €	+14.9%	-17,7 k €
Net result	3,2 M €	-22.5%	4,1 M €	-21.7%	5,3 M €	+199%	1,8 M €	-2.2%	1,8 M €	-59.4%	4,4 M €	+165%	1,7 M €	-15.6%	2 M €	-26.1%	2,7 M €	+68.1%	1,6 M €	-23.5%	2,1 M €	+103%	1 M €	+8.5%	946,4 k €	-10.2%	1,1 M €	+24.8%	844,6 k €	+112%	397,5 k €	+30.9%	303,7 k €	+34.8%	225,2 k €	+1434%	-16,9 k €	+6.0%	-18 k €
Balance sheet
Equity	35,7 M €	+9.8%	32,5 M €	+14.5%	28,4 M €	+22.7%	23,1 M €	+8.2%	21,4 M €	+9.2%	19,6 M €	+29.3%	15,1 M €	+12.4%	13,5 M €	+17.3%	11,5 M €	+30.5%	8,8 M €	+22.2%	7,2 M €	+40.9%	5,1 M €	+25.2%	4,1 M €	+30.2%	3,1 M €	+50.7%	2,1 M €	+68.4%	1,2 M €	+47.5%	837,7 k €	+56.9%	534 k €	+6027%	8,7 k €	+1359%	597,4 €
Total assets	68,7 M €	+5.3%	65,3 M €	+21.7%	53,6 M €	+23.0%	43,6 M €	+8.1%	40,4 M €	-24.7%	53,6 M €	+43.0%	37,5 M €	+10.6%	33,9 M €	-49.0%	66,4 M €	+112%	31,3 M €	-43.6%	55,4 M €	+185%	19,4 M €	+21.2%	16 M €	+30.0%	12,3 M €	+17.6%	10,5 M €	-13.6%	12,1 M €	+22.4%	9,9 M €	+95.3%	5,1 M €	+31026%	16,3 k €	+137%	6,9 k €
Cash	13 M €	-30.8%	18,8 M €	-0.6%	19 M €	-15.9%	22,5 M €	+12.9%	20 M €	+25.4%	15,9 M €	-5.0%	16,8 M €	+51.7%	11 M €	-62.1%	29,1 M €	+241%	8,5 M €	-67.8%	26,5 M €	+624%	3,7 M €	+13.1%	3,2 M €	+59.1%	2 M €	+999%	184,8 k €	-60.7%	470,3 k €	-77.2%	2,1 M €	+214%	657,8 k €	+5816%	11,1 k €	+146%	4,5 k €
Debts	33 M €	+0.9%	32,7 M €	+30.1%	25,2 M €	+27.3%	19,8 M €	+4.2%	19 M €	-44.3%	34 M €	+52.5%	22,3 M €	+9.6%	20,4 M €	-62.9%	54,8 M €	+145%	22,4 M €	-53.5%	48,1 M €	+237%	14,3 M €	+19.3%	12 M €	+30.0%	9,2 M €	+9.6%	8,4 M €	-22.9%	10,9 M €	+20.2%	9,1 M €	+101%	4,5 M €	+59278%	7,6 k €	+20.6%	6,3 k €
Other
Workforce	46,5 ETP	-7.4%	50,2 ETP	-1.4%	50,9 ETP	+11.4%	45,7 ETP	+14.0%	40,1 ETP	+4.2%	38,5 ETP	+4.6%	36,8 ETP	+16.8%	31,5 ETP	+1.6%	31,0 ETP	+1.3%	30,6 ETP	+18.6%	25,8 ETP	+35.8%	19,0 ETP	+21.8%	15,6 ETP	+19.1%	13,1 ETP	+36.5%	9,6 ETP	+39.1%	6,9 ETP	+6.2%	6,5 ETP	+364%	1,4 ETP		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 54 ended

Active mandates

Juan Peche Marin-Lázaro

Director · since 31 janvier 2025

Active

Josephine Yang Comiskey

Director · since 31 octobre 2024

Active

Luis Eduardo Viana De Oliveira Martins

Managing director · since 31 octobre 2024

Active

Sabine Tews

Managing director · since 01 juillet 2024

Active

Hans York-Julian Stücker

Director · since 01 février 2023

Active

Ended mandates

Andrew Jorden John

bestuurder · since 01 février 2023

Ended

Andrew JORDEN John

Director · since 01 février 2023

Ended

Elizabeth Dorling Janet

bestuurder · since 01 février 2023

Ended

Elizabeth DORLING Janet

Director · since 01 février 2023

Ended

At this address

Other companies at this address

Company	CBE no.
DBI Benelux● Active	0400.541.308
MEMORIA GROUP● Active	0798.958.415

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	26/05/2026	22/05/2025	22/05/2024	15/05/2023	25/05/2022	27/05/2021
General meeting	13/05/2026	14/05/2025	15/05/2024	10/05/2023	11/05/2022	12/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	13/05/2026	26/05/2026	Dutch	PDF
Full model	31/12/2024	14/05/2025	22/05/2025	Dutch	PDF
Full model	31/12/2023	15/05/2024	22/05/2024	Dutch	PDF
Full model	31/12/2022	10/05/2023	15/05/2023	Dutch	PDF
Full model	31/12/2021	11/05/2022	25/05/2022	Dutch	PDF
Full model	31/12/2020	12/05/2021	27/05/2021	Dutch	PDF
Full model	31/12/2019	20/05/2020	18/06/2020	Dutch	PDF
Full model	31/12/2018	08/05/2019	03/07/2019	Dutch	PDF
Full model	31/12/2017	09/05/2018	21/06/2018	Dutch	PDF
Full model	31/12/2016	10/05/2017	04/07/2017	Dutch	PDF
Full model	31/12/2015	11/05/2016	19/05/2016	Dutch	PDF
Full model	31/12/2014	10/09/2015	18/09/2015	Dutch	PDF
Full model	31/12/2013	14/05/2014	30/05/2014	Dutch	PDF
Full model	31/12/2012	08/05/2013	24/06/2013	Dutch	PDF
Full model	31/12/2011	23/07/2012	25/07/2012	Dutch	PDF
Full model	31/12/2010	25/07/2011	09/08/2011	Dutch	PDF
Full model	31/12/2009	13/01/2011	19/01/2011	Dutch	PDF
Full model	31/12/2008	12/10/2009	19/10/2009	Dutch	PDF
Full model	31/12/2007	14/05/2008	23/06/2008	French	PDF
Full model	31/12/2006	09/05/2007	08/06/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 54 ended

Active mandates

Juan Peche Marin-Lázaro

Director · since 31 janvier 2025

Active

Josephine Yang Comiskey

Director · since 31 octobre 2024

Active

Luis Eduardo Viana De Oliveira Martins

Managing director · since 31 octobre 2024

Active

Sabine Tews

Managing director · since 01 juillet 2024

Active

Hans York-Julian Stücker

Director · since 01 février 2023

Active

Ended mandates

Andrew Jorden John

bestuurder · since 01 février 2023

Ended

Andrew JORDEN John

Director · since 01 février 2023

Ended

Elizabeth Dorling Janet

bestuurder · since 01 février 2023

Ended

Elizabeth DORLING Janet

Director · since 01 février 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates31/12/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/06/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates20/02/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/11/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/07/2024
ONTSLAGEN - BENOEMINGEN
PDF
Other23/07/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates03/06/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/03/2023
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20253,2 M €↓
31/01/2025
nominationJ.Peche Marín-Lázaro — bestuurder
2024
Annual accounts 20244,1 M €↓
31/10/2024
nominationJosephine Yang Comiskey — bestuurder
31/10/2024
nominationLuis Eduardo Viana de Oliveira Martins — bestuurder
01/07/2024
nominationSabine Tews — bestuurder
01/07/2024
nominationMarc Esque Ingles — gedelegeerd bestuurder
10/05/2024
reconductionERNST EN YOUNG BEDRIJFSREVISOREN BV — commissaris
10/05/2024
nominationEef NAESSENS — vaste vertegenwoordiger
2023
Annual accounts 20235,3 M €↑
01/02/2023
nominationHans York-Julian Stücker — bestuurder
01/02/2023
nominationJohn Andrew Jorden — bestuurder
01/02/2023
nominationJanet Elizabeth Dorling — bestuurder
01/02/2023
nominationMarc Esque Ingles — bestuurder
2022
Annual accounts 20221,8 M €↓
06/10/2022
autre
01/06/2022
nominationLuis MIRANDA RUBI — bestuurder
2021
Annual accounts 20211,8 M €↓
2020
Annual accounts 20204,4 M €↑
2019
Annual accounts 20191,7 M €↓
2018
Annual accounts 20182 M €↓
2017
Annual accounts 20172,7 M €↑
2016
Annual accounts 20161,6 M €↓
2015
Annual accounts 20152,1 M €↑
2014
Annual accounts 20141 M €↑
2013
Annual accounts 2013946,4 k €↓
2012
Annual accounts 20121,1 M €↑
2011
Annual accounts 2011844,6 k €↑
2010
Annual accounts 2010397,5 k €↑
2009
Annual accounts 2009303,7 k €↑
2008
Annual accounts 2008225,2 k €↑
2007
Annual accounts 2007-16,9 k €↑
2006
Annual accounts 2006-18 k €
17/07/2006
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

GILEAD SCIENCES BELGIUM

Overview

What does GILEAD SCIENCES BELGIUM do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline